I agree with Denial. Only 17 MPS I and VI patients will/have received iPPS in the trials and no amazing results have occurred according to the information released so far for MPS I. I'd think no more than $20-25mill will be paid by a pharma. to have a punt on iPPS for all lysosomal conditions.
Results for MPS VI are still not due out until the end of the year so they'll need a capital raise before they potentially receive this money which would be lucky to tie PAR over for 3-4 months.
I agree with Denial. Only 17 MPS I and VI patients will/have...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.005(2.56%) |
Mkt cap ! $70.04M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.5¢ | 19.5¢ | $114.9K | 583.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 46251 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 185907 | 7 |
View Market Depth
| Last trade - 14.05pm 09/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |